Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Paving the Road for RNA Therapeutics
Niels Dammes, Dan Peer
Trends in Pharmacological Sciences (2020) Vol. 41, Iss. 10, pp. 755-775
Open Access | Times Cited: 187

Showing 1-25 of 187 citing articles:

Self-assembled mRNA vaccines
Jeonghwan Kim, Yulia Eygeris, Mohit Gupta, et al.
Advanced Drug Delivery Reviews (2021) Vol. 170, pp. 83-112
Open Access | Times Cited: 377
A noninflammatory mRNA vaccine for treatment of experimental autoimmune encephalomyelitis
Christina Krienke, LAURA D. KOLB, Elif Diken, et al.
Science (2021) Vol. 371, Iss. 6525, pp. 145-153
Closed Access | Times Cited: 346
Evolution of drug delivery systems: From 1950 to 2020 and beyond
Haesun Park, Andrew Otte, Kinam Park
Journal of Controlled Release (2021) Vol. 342, pp. 53-65
Open Access | Times Cited: 280
Liquid–liquid phase separation drives cellular function and dysfunction in cancer
Sohum Mehta, Jin Zhang
Nature reviews. Cancer (2022) Vol. 22, Iss. 4, pp. 239-252
Open Access | Times Cited: 246
Cytosolic delivery of nucleic acids: The case of ionizable lipid nanoparticles
Michele Schlich, Roberto Palomba, Gabriella Costabile, et al.
Bioengineering & Translational Medicine (2021) Vol. 6, Iss. 2
Open Access | Times Cited: 234
Manufacturing Considerations for the Development of Lipid Nanoparticles Using Microfluidics
Carla B. Roces, Gustavo Lou, Nikita Jain, et al.
Pharmaceutics (2020) Vol. 12, Iss. 11, pp. 1095-1095
Open Access | Times Cited: 205
Anionic Lipid Nanoparticles Preferentially Deliver mRNA to the Hepatic Reticuloendothelial System
Roy Pattipeiluhu, Gabriela Arias‐Alpizar, Genc Basha, et al.
Advanced Materials (2022) Vol. 34, Iss. 16
Open Access | Times Cited: 131
Endosomal escape of delivered mRNA from endosomal recycling tubules visualized at the nanoscale
Prasath Paramasivam, Christian Franke, Martin Stöter, et al.
The Journal of Cell Biology (2021) Vol. 221, Iss. 2
Open Access | Times Cited: 129
Intravesical delivery of KDM6A -mRNA via mucoadhesive nanoparticles inhibits the metastasis of bladder cancer
Na Kong, Ruonan Zhang, Gongwei Wu, et al.
Proceedings of the National Academy of Sciences (2022) Vol. 119, Iss. 7
Open Access | Times Cited: 121
Clinical delivery of circular RNA: Lessons learned from RNA drug development
Tiana L. Young, Kevin Chang Wang, Andrew Varley, et al.
Advanced Drug Delivery Reviews (2023) Vol. 197, pp. 114826-114826
Closed Access | Times Cited: 68
The landscape of nanoparticle-based siRNA delivery and therapeutic development
Muhammad Moazzam, Jun Zhang, Abid Hussain, et al.
Molecular Therapy (2024) Vol. 32, Iss. 2, pp. 284-312
Closed Access | Times Cited: 44
Resources, Production Scales and Time Required for Producing RNA Vaccines for the Global Pandemic Demand
Zoltán Kis, Cleo Kontoravdi, Robin J. Shattock, et al.
Vaccines (2020) Vol. 9, Iss. 1, pp. 3-3
Open Access | Times Cited: 115
Key points for the development of antioxidant cocktails to prevent cellular stress and damage caused by reactive oxygen species (ROS) during manned space missions
Xavier Gómez, Serena Sanon, Kevin Zambrano, et al.
npj Microgravity (2021) Vol. 7, Iss. 1
Open Access | Times Cited: 63
Robust delivery of RIG‐I agonists using extracellular vesicles for anti‐cancer immunotherapy
Boya Peng, Trinh Mai Nguyen, Migara Kavishka Jayasinghe, et al.
Journal of Extracellular Vesicles (2022) Vol. 11, Iss. 4
Open Access | Times Cited: 58
Synthetic modified messenger RNA for therapeutic applications
Minsong Gao, Qingyi Zhang, Xin‐Hua Feng, et al.
Acta Biomaterialia (2021) Vol. 131, pp. 1-15
Open Access | Times Cited: 57
Biomolecular condensates: new opportunities for drug discovery and RNA therapeutics
Brooke A. Conti, Mariano Oppikofer
Trends in Pharmacological Sciences (2022) Vol. 43, Iss. 10, pp. 820-837
Open Access | Times Cited: 56
Advanced Microfluidic Technologies for Lipid Nano-Microsystems from Synthesis to Biological Application
Bruna G. Carvalho, Bruno Telli Ceccato, Mariano Michelon, et al.
Pharmaceutics (2022) Vol. 14, Iss. 1, pp. 141-141
Open Access | Times Cited: 53
Overcoming doxorubicin resistance in cancer: siRNA-loaded nanoarchitectures for cancer gene therapy
Mahshid Deldar Abad Paskeh, Hamidreza Saebfar, Mahmood Khaksary Mahabady, et al.
Life Sciences (2022) Vol. 298, pp. 120463-120463
Open Access | Times Cited: 51
RNAJP: enhanced RNA 3D structure predictions with non-canonical interactions and global topology sampling
Jun Li, Shi‐Jie Chen
Nucleic Acids Research (2023) Vol. 51, Iss. 7, pp. 3341-3356
Open Access | Times Cited: 24
RNA Oncological Therapeutics: Intracellular Hairpin RNA Assembly Enables MicroRNA-Triggered Anticancer Functionality
Kunihiko Morihiro, Shunto Morita, Naoki Harada, et al.
Journal of the American Chemical Society (2024) Vol. 146, Iss. 2, pp. 1346-1355
Closed Access | Times Cited: 9
Targeted delivery systems of siRNA based on ionizable lipid nanoparticles and cationic polymer vectors
Zhao Yao, Taiqing Liu, Jingwen Wang, et al.
Biotechnology Advances (2025) Vol. 81, pp. 108546-108546
Closed Access | Times Cited: 1
Mesenchymal stromal (stem) cell therapy modulates miR-193b-5p expression to attenuate sepsis-induced acute lung injury
Claúdia C. dos Santos, Hajera Amatullah, Chirag M. Vaswani, et al.
European Respiratory Journal (2021) Vol. 59, Iss. 1, pp. 2004216-2004216
Open Access | Times Cited: 55
RNA modifications in cardiovascular diseases, the potential therapeutic targets
Yirong Wu, Siyao Zhan, Yizhou Xu, et al.
Life Sciences (2021) Vol. 278, pp. 119565-119565
Closed Access | Times Cited: 54
Opportunities and challenges for microRNA-targeting therapeutics for epilepsy
Gareth Morris, Denis O’Brien, David C. Henshall
Trends in Pharmacological Sciences (2021) Vol. 42, Iss. 7, pp. 605-616
Open Access | Times Cited: 49
siRNA Functionalized Lipid Nanoparticles (LNPs) in Management of Diseases
Tutu Kalita, Saba Abbasi Dezfouli, Lalit M. Pandey, et al.
Pharmaceutics (2022) Vol. 14, Iss. 11, pp. 2520-2520
Open Access | Times Cited: 37
Page 1 - Next Page

Scroll to top